Literature DB >> 34120515

The Experiences of COVID-19 Patients in Intensive Care Units: A Qualitative Study.

Meltem Kürtüncü1, Aylin Kurt2, Nurten Arslan3.   

Abstract

This exploratory qualitative study explores the experiences of COVID-19 patients in intensive care units and after discharge. Semi- structured telephone interviews were conducted with 18 COVID-19 patients admitted to and discharged from intensive care units between March and September in 2020. The themes of this study were determined as "feelings about the illness and intensive care," "psychological and physical damages," "nurses' efforts and the importance of care.", and "protecting health and life". COVID-19 patients in intensive care units may experience permanent physical and psychological damages. The findings suggest that the first step in carrying out interventions in the intensive care units is to ensure that continuous communication with patients is maintained so that their orientation to the new circumstances can be achieved. Nursing interventions to patients missing their families can have compensated for the loss of family support and care during their critical illness.

Entities:  

Keywords:  COVID-19; intensive care units; pandemics; patients; qualitative research

Year:  2021        PMID: 34120515     DOI: 10.1177/00302228211024120

Source DB:  PubMed          Journal:  Omega (Westport)        ISSN: 0030-2228


  2 in total

1.  Experiences, Emotions, and Health Consequences among COVID-19 Survivors after Intensive Care Unit Hospitalization.

Authors:  Ilenia Piras; Maria Francesca Piazza; Cristina Piccolo; Antonio Azara; Andrea Piana; Gabriele Finco; Maura Galletta
Journal:  Int J Environ Res Public Health       Date:  2022-05-21       Impact factor: 4.614

2.  Experiences of COVID-19 patients in a Fangcang shelter hospital in China during the first wave of the COVID-19 pandemic: a qualitative descriptive study.

Authors:  Yaping Zhong; Huan Zhao; Tsorng-Yeh Lee; Tianchi Yu; Ming Fang Liu; Ji Ji
Journal:  BMJ Open       Date:  2022-09-14       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.